home / stock / famdf / famdf quote
Last: | $0.42 |
---|---|
Change Percent: | 0.0% |
Open: | $0.42 |
Close: | $0.42 |
High: | $0.42 |
Low: | $0.4 |
Volume: | 8,700 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.42 | $0.42 | $0.42 | $0.42 | $0.4 | 8,700 | 04-29-2024 |
$0.42 | $0.5 | $0.42 | $0.5 | $0.42 | 13,000 | 04-26-2024 |
$0.38 | $0.38 | $0.38 | $0.38 | $0.38 | 3,044 | 04-25-2024 |
$0.45 | $0.45 | $0.45 | $0.45 | $0.45 | 1,750 | 04-24-2024 |
$0.4 | $0.4 | $0.4 | $0.4 | $0.4 | 1,000 | 04-23-2024 |
$0.422 | $0.422 | $0.422 | $0.422 | $0.422 | 577 | 04-22-2024 |
$0.42 | $0.43 | $0.42 | $0.43 | $0.42 | 23,777 | 04-19-2024 |
$0.46 | $0.459 | $0.46 | $0.46 | $0.459 | 2,300 | 04-18-2024 |
$0.48 | $0.48 | $0.48 | $0.48 | $0.48 | 5,000 | 04-17-2024 |
$0.44 | $0.42 | $0.44 | $0.44 | $0.42 | 26,110 | 04-16-2024 |
$0.42 | $0.59 | $0.42 | $0.55 | $0.38 | 40,000 | 04-15-2024 |
$0.45 | $0.4 | $0.45 | $0.45 | $0.4 | 61,029 | 04-12-2024 |
$0.5 | $0.4507 | $0.5 | $0.5 | $0.4507 | 12,000 | 04-11-2024 |
$0.46 | $0.5 | $0.46 | $0.5 | $0.46 | 12,500 | 04-10-2024 |
$0.5 | $0.51 | $0.5 | $0.51 | $0.5 | 27,000 | 04-09-2024 |
$0.491 | $0.6 | $0.491 | $0.6 | $0.491 | 3,500 | 04-08-2024 |
$0.49 | $0.49 | $0.49 | $0.49 | $0.49 | 2,000 | 04-05-2024 |
$0.4507 | $0.47 | $0.4507 | $0.47 | $0.4507 | 12,100 | 04-04-2024 |
$0.48 | $0.49 | $0.48 | $0.6 | $0.4507 | 20,180 | 04-03-2024 |
$0.47 | $0.53 | $0.47 | $0.53 | $0.47 | 10,760 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Futura Medical Plc Ord Company Name:
FAMDF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder tells Proactive's Stephen Gunnion about a strategic shift and refresh for the company in 2023, marked by the successful launch of Eroxon in the UK and Belgium, generating £3.1 million in revenues, FDA marketing aut...
(NewsDirect) Futura Medical PLC CEO James Barder tells Proactive's Stephen Gunnion that 2023 was a pivotal year for the company as it rolled out its innovative sexual health product, Eroxon, designed to treat erectile dysfunction. The over-the-counter availability of Eroxon distinguis...
(NewsDirect) Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive London after the pharmaceutical company announced another milestone in its global expansion efforts. Barder shares the news that the Futura has reached an agreement to expand i...